Molecular Characterization and Antifungal Susceptibility of <i>Aspergillus</i> spp. among Patients with Underlying Lung Diseases
Background. Pulmonary aspergillosis is a lung infection caused by <i>Aspergillus</i> spp., which can cause severe illnesses in immunocompromised patients with underlying lung disease or who have asthma and inhale their spores. This study aimed to screen the antifungal susceptibility of &...
Main Authors: | Ehssan Moglad, Samar Saeed, Humodi Saeed, Hind Ahmed, Kwathar Salih, Hisham Altayb, Wafa Elhag |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Tropical Medicine and Infectious Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2414-6366/7/10/274 |
Similar Items
-
Khartoum
Published: (1968) -
Unravelling the Molecular Identification and Antifungal Susceptibility Profiles of <i>Aspergillus</i> spp. Isolated from Chronic Pulmonary Aspergillosis Patients in Jakarta, Indonesia: The Emergence of Cryptic Species
by: Anna Rozaliyani, et al.
Published: (2022-04-01) -
Siderophore Scaffold as Carrier for Antifungal Peptides in Therapy of <i>Aspergillus fumigatus</i> Infections
by: Joachim Pfister, et al.
Published: (2020-12-01) -
Inappropriate treatment of pulmonary aspergillosis caused by Aspergillus flavus in susceptible pediatric patients: a case series
by: Neginsadat Hosseinikargar, et al.
Published: (2024-07-01) -
Antifungal Treatment for Japanese Patients with Chronic Pulmonary Aspergillosis
by: Takahiro Takazono, et al.
Published: (2024-12-01)